| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |